Soaked Pharyngeal Packing Agents in Septoplasty
Throat pack
Comparative Evaluation of Soaked Pharyngeal Packing Agents in Septoplasty Procedure: Impact on Postoperative Outcomes
1 other identifier
interventional
65
1 country
1
Brief Summary
Postoperative sore throat (POST) is a frequent and distressing complication after general anesthesia with endotracheal intubation, particularly in nasal surgery for example, functional endoscopic sinus surgery, septoplasty, or septo-rhinoplasty, where pharyngeal packing is routine. While pharyngeal packs may reduce blood ingestion, they may exacerbate POST, warranting effective pharmacologic prophylaxis. This study assesses the efficacy of dexamethasone-soaked pharyngeal packs in reducing incidence of POST in patients undergoing elective septoplasty surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Mar 2026
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 20, 2026
CompletedStudy Start
First participant enrolled
March 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2026
CompletedMay 7, 2026
May 1, 2026
1 month
March 16, 2026
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative sore throat (POST) score: 4-point scale as 0 for no sore throat (better outcome), and 3 for severe sore throat associated with hoarseness (worse outcome).
The incidence of postoperative sore throat (POST) at 1-hour post-surgery and assessment will be done at Post Anesthesia Care Unit (PACU) every 30 minutes for 1 hour (at Post Anesthesia Care Unit (PACU) admission, 30, and 60 minutes).
1 hour
Secondary Outcomes (3)
Postoperative Sore Throat (POST) score: 4-point scale as 0 for no sore throat (better outcome) and 3 for severe sore throat associated with hoarseness (worse outcome).
24 hours
Postoperative nausea and vomiting (PONV) score: A 4-point scale with 0 for absence of nausea and vomiting (better outcome), and 3 for postoperative nausea accompanied by vomiting (worse outcome).
6 hours
Visual Analogue Scale (VAS) pain score: a 10 cm Visual Analog Scale, where 0 indicated no pain (better outcome), and 10 the worst imaginable pain (worse outcome).
24 hours
Study Arms (2)
Placebo
PLACEBO COMPARATORA sterile, non-absorbable gauze strip that will be between 30 and 50 cm² in size and with a retrieval thread for atraumatic removal made, then for 30 seconds, the gauze is submerged in 25 ml of normal saline solution
Dexamethasone
ACTIVE COMPARATORA sterile, non-absorbable gauze strip that will be between 30 and 50 cm² in size and with a retrieval thread for atraumatic removal made, then for 30 seconds, the gauze is submerged in 8 mg dexamethasone and 25 ml of normal saline solution
Interventions
The anesthetist, unaware of group allocation, will place the saline soaked pharyngeal pack under direct visualization following intubation. The pharyngeal pack will be situated in the oropharynx, positioned posterior to the soft palate and in contact with the posterior pharyngeal wall. Placement will be executed with forceps under direct observation, adhering to a standardized protocol to guarantee uniformity across all patients.
The anesthetist, unaware of group allocation, will place the dexamethasone soaked pharyngeal pack under direct visualization following intubation. The pharyngeal pack will be situated in the oropharynx, positioned posterior to the soft palate and in contact with the posterior pharyngeal wall. Placement will be executed with forceps under direct observation, adhering to a standardized protocol to guarantee uniformity across all patients.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65 years,
- Both male and female,
- Classified as American Society of Anesthesiologists (ASA) physical status I to III, and
- Scheduled for elective septoplasty.
You may not qualify if:
- Preoperative sore throat,
- Recent upper respiratory infections,
- Anticipated difficult airway,
- Existing digestive, respiratory, or cervical conditions,
- Regular smoking,
- Steroid use within 48 hours prior to surgery, and
- Pregnancy.
- Patients on chronic corticosteroid therapy, antitussives, or antihypertensive medications
- With known effects on airway reactivity or bleeding risk,
- Those with uncontrolled hypertension, or
- With known allergies to any of the study medications or their components
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 71511, Egypt
Related Publications (1)
Mazzotta E, Soghomonyan S, Hu LQ. Postoperative sore throat: prophylaxis and treatment. Front Pharmacol. 2023 Nov 23;14:1284071. doi: 10.3389/fphar.2023.1284071. eCollection 2023.
PMID: 38074131RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 20, 2026
Study Start
March 20, 2026
Primary Completion
April 25, 2026
Study Completion
April 27, 2026
Last Updated
May 7, 2026
Record last verified: 2026-05